Cara

STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today…

By Express News Service How would you describe Carnival Row and your role in it for someone who might be new to the show? It is dark and violent, but also beautiful, magical and romantic. I play a fairy or a fae…

The Mandalorian Season 3 Episode 1 Chapter 17 came out yesterday on March 1, 2023 and fans could not be happier. They finally got to reunite with their beloved characters Din Djarin played by Pedro Pascal and Grogu. The cast and…

Issued on: 26/11/2022 - 21:05 Irene Cara, an Oscar-winning singer and actress who recorded the title tracks to the blockbuster 1980s movies "Fame" and "Flashdance," has died…

NEW YORK — Oscar, Golden Globe and two-time Grammy winning singer-actress Irene Cara, who starred and sang the title cut from the 1980 hit movie Fame and then belted out the era-defining hit "Flashdance ... What a Feeling" from…

NEW YORK (AP) — Oscar, Golden Globe and two-time Grammy winning singer-actress Irene Cara, who starred and sang the title cut from the 1980 hit movie “Fame” and then belted out the era-defining hit “Flashdance ... What a…

By Paradise Afshar, CNN Academy Award winner Irene Cara, best known for singing the theme songs for "Fame" and "Flashdance," has died in her Florida home, according to a statement from her publicist…

– Net revenue was $16.2M for 3Q22 including profit-sharing revenue of $7.4M from KORSUVA® (difelikefalin) injection – – Strong demand for KORSUVA injection driven by large dialysis organizations with ~180,000 vials shipped – – FDA…

– Net revenue was $23M for 2Q 2022 comprised of profit-sharing revenue of $8M from KORSUVA™ (difelikefalin) injection and a $15M milestone payment from the European Commission approval of Kapruvia® (difelikefalin) – – KOMFORT…

STAMFORD, Conn., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today…